Wednesday, August 02, 2017 5:03:13 PM
I'm intrigued with this response to the question of where are they at with respect to Novartis and possible combination therapies. The response was/is: "I can't talk about that now". OK, that tells me something because if you read the post I'm currently responding to, I highlight a quote from a previous CC: (#msg-131090158) asking the very SAME question. The answer, curiously back then, is that it can't be discussed until after the license is in place ($7mil payment completed) later this year. Well, the payment has been made so why can't you discuss it now? Makes me go hmmmmmmmmmmmmmmmmmmmmmmmmmm
Theo 
;-)
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
